You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
|
|---|---|
| Published in |
BMC Cancer, November 2011
|
| DOI | 10.1186/1471-2407-11-486 |
| Pubmed ID | |
| Authors |
Peter A Fasching, Katharina Heusinger, Lothar Haeberle, Melitta Niklos, Alexander Hein, Christian M Bayer, Claudia Rauh, Ruediger Schulz-Wendtland, Mayada R Bani, Michael Schrauder, Laura Kahmann, Michael P Lux, Johanna D Strehl, Arndt Hartmann, Arno Dimmler, Matthias W Beckmann, David L Wachter |
| Abstract |
The pathological complete response (pCR) after neoadjuvant chemotherapy is a surrogate marker for a favorable prognosis in breast cancer patients. Factors capable of predicting a pCR, such as the proliferation marker Ki67, may therefore help improve our understanding of the drug response and its effect on the prognosis. This study investigated the predictive and prognostic value of Ki67 in patients with invasive breast cancer receiving neoadjuvant treatment for breast cancer. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 1 | 25% |
| United States | 1 | 25% |
| Unknown | 2 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 75% |
| Practitioners (doctors, other healthcare professionals) | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 173 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | 1% |
| Germany | 1 | <1% |
| Unknown | 170 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 25 | 14% |
| Student > Master | 21 | 12% |
| Student > Bachelor | 20 | 12% |
| Student > Ph. D. Student | 19 | 11% |
| Student > Doctoral Student | 9 | 5% |
| Other | 33 | 19% |
| Unknown | 46 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 62 | 36% |
| Agricultural and Biological Sciences | 27 | 16% |
| Biochemistry, Genetics and Molecular Biology | 14 | 8% |
| Unspecified | 4 | 2% |
| Nursing and Health Professions | 3 | 2% |
| Other | 13 | 8% |
| Unknown | 50 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 April 2019.
All research outputs
#5,414,361
of 22,656,971 outputs
Outputs from BMC Cancer
#1,316
of 8,238 outputs
Outputs of similar age
#33,103
of 141,521 outputs
Outputs of similar age from BMC Cancer
#9
of 93 outputs
Altmetric has tracked 22,656,971 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,238 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 141,521 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 93 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.